As the cooccurrence of SLC20A2-associated PFBC with dopamine-responsive parkinsonism is very unusual (3, 8–11), monitoring the dopamine responsiveness of the patient to assess the possible benefits of dopamine replacement therapy is essential. Here, SLC20A2 is linked to Parkinsonism.